ABO(H) cell surface antigens in parathyroid adenoma and hyperplasia.
Forty-three cases of primary hyperparathyroidism were studied with the specific red cell adherence test (SRCA) to determine the presence or absence of ABO(H) cell surface antigens on abnormal parathyroid tissue. Of the 27 patients with the clinicopathologic diagnosis (CPD) of adenoma, 24 (89%) had lost the ABO(H) cell surface antigen of the abnormal gland. Among the 15 patients with the CPD of hyperplasia, the parathyroid tissue from three (20%) had lost its red cell antigen. In one patient, a metastasis from a parathyroid carcinoma had lost the ABO surface antigen. Several patients in whom conflicting SRCA and CPD were obtained had factors that raised doubts as to the validity of their CPD. The SRCA is a simple test that may aid in the difficult differentiation between parathyroid adenoma and hyperplasia.
D000017:ABO Blood-Group System; D000236:Adenoma / Q000097:blood* / Q000175:diagnosis / Q000276:immunology; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006965:Hyperplasia; D007158:Immunologic Techniques; D008297:Male; D008875:Middle Aged; D010280:Parathyroid Glands / Q000276:immunology* / Q000473:pathology; D010282:Parathyroid Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000276:immunology
D000017:ABO Blood-Group System